CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $248.29M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score -4.73: distress zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
248.29MUSDvs all stocks (USD)
Revenue (TTM)
219.06MUSDvs all stocks (USD)
Profit Margin
-13.54%Beta
0.1910xvs all stocks
52-Week Change
-66.94%vs all stocks
Market Capitalization
248.29MUSDvs all stocks (USD)
Enterprise Value
291.98MUSDvs all stocks (USD)
Forward P/E
-2.49xPrice to Sales (TTM)
1.13xPrice to Book (MRQ)
9.74xEnterprise to Revenue
1.33xEnterprise to EBITDA
-67.97xGross Margin
78.78%Profit Margin
-13.54%Operating Margin
-5.46%Return on Assets (TTM)
-1.05%Return on Equity (TTM)
-109.38%Revenue (TTM)
219.06MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.8210USDUpdated Sep 26, 2026Quarterly Revenue Growth
-21.40%Gross Profit (TTM)
178.40MUSDvs all stocks (USD)
EBITDA (TTM)
24.83MUSDvs all stocks (USD)
Net Income (TTM)
-29.67MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-21.36%Operating Cash Flow (TTM)
41.55MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
33.64MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 26, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
236.20MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
39.46MUSDFY2025 · Dec 31, 2025Gross Profit
196.73MUSDFY2025 · Dec 31, 2025Operating Income
23.50MUSDvs all stocks (USD)
Pre-tax Income
-3.72MUSDFY2025 · Dec 31, 2025Income Tax Expense
1.62MUSDFY2025 · Dec 31, 2025Net Income
-5.34MUSDFY2025 · Dec 31, 2025EBIT
20.46MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
24.83MUSDFY2025 · Dec 31, 2025Research & Development
62.36MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
107.48MUSDFY2025 · Dec 31, 2025Other Operating Expenses
3.40MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
24.18MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.0200USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.0200USDFY2025 · Dec 31, 2025Basic Shares Outstanding
257.16MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
257.16MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-5.34MUSDFY2025 · Dec 31, 2025Operating Cash Flow
4.97MUSDFY2025 · Dec 31, 2025Free Cash Flow
4.85MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
186.54MUSDFY2025 · Dec 31, 2025Interest Paid
6.08MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-5.34MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
1.27MUSDFY2025 · Dec 31, 2025Stock-based Compensation
11.28MUSDFY2025 · Dec 31, 2025Other Non-cash Items
37.40MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-14.14MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
3.08MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-28.58MUSDFY2025 · Dec 31, 2025Capital Expenditures
-119.00KUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-7.81MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-119.00KUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
10.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-462.00KUSDFY2025 · Dec 31, 2025Other Financing Charges
-4.97MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
71.24MUSDFY2025 · Dec 31, 2025Shares Outstanding
271.74MSharesUpdated Sep 26, 2026Float Shares
270.60MSharesUpdated Sep 26, 2026Shares Short
20.50MSharesUpdated Sep 26, 2026Short Ratio
2.35daysvs all stocks
Short % of Shares Outstanding
7.51%vs all stocks
% Held by Insiders
4.06%vs all stocks
% Held by Institutions
42.87%vs all stocks
Total Cash (MRQ)
155.55MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.5610USDUpdated Sep 26, 2026Total Debt (MRQ)
199.19MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
7.96xCurrent Ratio (MRQ)
1.43xBook Value per Share (MRQ)
0.0920USDUpdated Sep 26, 2026Total Assets
376.56MUSDvs all stocks (USD)
Total Current Assets
252.96MUSDFY2025 · Dec 31, 2025Total Liabilities
343.95MUSDFY2025 · Dec 31, 2025Total Non-current Assets
123.61MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
181.02MUSDFY2025 · Dec 31, 2025Total Current Liabilities
162.94MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
184.84MUSDFY2025 · Dec 31, 2025Accounts Receivable
47.03MUSDFY2025 · Dec 31, 2025Inventory
15.61MUSDFY2025 · Dec 31, 2025Accounts Payable
21.18MUSDFY2025 · Dec 31, 2025Short-term Debt
3.55MUSDFY2025 · Dec 31, 2025Deferred Revenue
2.68MUSDFY2025 · Dec 31, 2025Other Current Liabilities
86.52MUSDFY2025 · Dec 31, 2025Long-term Debt
48.25MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
107.18MUSDFY2025 · Dec 31, 2025Common Stock (Book)
2.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-1.68BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
32.61MUSDvs all stocks (USD)
52-Week Low
0.8140USDUpdated Sep 26, 202652-Week High
3.20USDUpdated Sep 26, 202652-Week Change
-66.94%vs all stocks
Beta
0.1910xvs all stocks
50-Day MA
1.03USDUpdated Sep 26, 2026200-Day MA
1.25USDUpdated Sep 26, 2026Avg 10-Day Volume
6.79MSharesUpdated Sep 26, 2026Avg 30-Day Volume
7.95MSharesUpdated Sep 26, 2026Diluted EPS (TTM)
-0.1200USDUpdated Sep 26, 2026Other Income / Expense
-3.04MUSDFY2025 · Dec 31, 20253 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.79Profit Margin: -0.14
Significant cash reserves alongside high leverageNotable
Cash (USD): 155,548,000Total Debt (USD): 199,188,000Debt-to-Equity: 7.96
Financial Health
Altman Z-Score -4.73: distress zoneCritical
Altman Z-Score: -4.73
High structural barrier to entryNotable
Barrier to Entry: 0.57
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $248.29M, lower than 95% of all stocks globallySignificant
Market cap (USD): 248,287,203Global P5: 275,556,405.438
Levered free cash flow is $33.64M, above the global median of $18.73MNotable
Levered free cash flow (USD): 33,636,376Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Heartseed Inc.
Tier 1ProductionApproval-Gated PipelineRule
Siga Technologies Inc.
Tier 1ProductionApproval-Gated PipelineRule
United Orthopedic Corporation
Tier 1ProductionApproval-Gated PipelineRule
Acimmune SA
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Daito Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
PharmaEngine, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hangzhou Jiuyuan Gene Engineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sisram Medical Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Palisade Bio Inc.
Tier 1ProductionApproval-Gated PipelineRule
Seikagaku Corporation
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
CommScope Holding Company, Inc.
3 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And DrawdownWithin or Near the Altman Distress Zone
T1 Energy Inc.
3 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And DrawdownWithin or Near the Altman Distress Zone
Guosheng Shian Technology Co., Ltd.
3 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And DrawdownWithin or Near the Altman Distress Zone